With the improving pandemic conditions, the companies are expected to gain targeted customers. Due to this, in the optimistic scenario, the overall revenue of the companies is expected to grow. In addition, due to the ease of lockdown restrictions, it is expected that the market for pharmacogenomics services will grow tremendously during the forecast period 2021-2031.
Global pharmacogenomics services market (by application) has been dominated by core genetic tool-based applications. These applications primarily include pharmacogenomics products extensively used for the diagnosis of oncology, infectious disease, psychiatry, endocrinology, cardiovascular, gastroenterology, and other applications. Neurology/psychiatry is one of the highest growing application segments for the market.
With the improving pandemic conditions, the companies are expected to gain targeted customers. Due to this, in the optimistic scenario, the overall revenue of the companies is expected to grow. In addition, due to the ease of lockdown restrictions, it is expected that the market for pharmacogenomics services will grow tremendously during the forecast period 2021-2031.
Global pharmacogenomics services market (by application) has been dominated by core genetic tool-based applications. These applications primarily include pharmacogenomics products extensively used for the diagnosis of oncology, infectious disease, psychiatry, endocrinology, cardiovascular, gastroenterology, and other applications. Neurology/psychiatry is one of the highest growing application segments for the market.